世界の血漿プロテアーゼC1阻害剤治療市場2019

• 英文タイトル：Global Plasma Protease C1-inhibitor Treatment Sales Market Report 2019

• レポートコード：QYR9N3459
• 出版社/出版日：QYResearch / 2019年6月13日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、101ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥600,000 (USD4,000)	▷ お問い合わせ
Enterprise License	￥1,200,000 (USD8,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本調査レポートでは、血漿プロテアーゼC1阻害剤治療の世界市場について調査・分析し、血漿プロテアーゼC1阻害剤治療のメーカー別販売量、市場シェア分析、種類別販売分析（C1阻害剤、カリクレインインヒビター（Kalbitor）、選択的ブラジキニンB2受容体拮抗薬（Firazyr））、用途別販売分析（病院薬局、独立した薬局とアウトレット）、地域別販売分析（米国、ヨーロッパ、中国、日本、東南アジア、インド）、価格動向、企業動向、市場規模予測などを含め、以下の構成でお届けいたします。

・血漿プロテアーゼC1阻害剤治療市場概要
・血漿プロテアーゼC1阻害剤治療のメーカー別販売量・メーカー別シェア
・血漿プロテアーゼC1阻害剤治療の種類別販売量（C1阻害剤、カリクレインインヒビター（Kalbitor）、選択的ブラジキニンB2受容体拮抗薬（Firazyr））
・血漿プロテアーゼC1阻害剤治療の用途別販売量（病院薬局、独立した薬局とアウトレット）
・血漿プロテアーゼC1阻害剤治療の地域別販売量・市場シェア
・血漿プロテアーゼC1阻害剤治療の米国市場規模（2014年-2019年）
・血漿プロテアーゼC1阻害剤治療のヨーロッパ市場規模（2014年-2019年）
・血漿プロテアーゼC1阻害剤治療の中国市場規模（2014年-2019年）
・血漿プロテアーゼC1阻害剤治療の日本市場規模（2014年-2019年）
・血漿プロテアーゼC1阻害剤治療の東南アジア市場規模（2014年-2019年）
・血漿プロテアーゼC1阻害剤治療のインド市場規模（2014年-2019年）
・血漿プロテアーゼC1阻害剤治療メーカー分析（企業概要、製品概要、販売量、売上、価格等）
・血漿プロテアーゼC1阻害剤治療のコスト分析
・血漿プロテアーゼC1阻害剤治療販売チャネル、流通業者、顧客
・血漿プロテアーゼC1阻害剤治療の世界市場動向・機会・成長要因・課題
・血漿プロテアーゼC1阻害剤治療の種類別世界市場予測（C1阻害剤、カリクレインインヒビター（Kalbitor）、選択的ブラジキニンB2受容体拮抗薬（Firazyr））
・血漿プロテアーゼC1阻害剤治療の用途別世界市場予測（病院薬局、独立した薬局とアウトレット）
・血漿プロテアーゼC1阻害剤治療の米国市場予測（2019年-2025年）
・血漿プロテアーゼC1阻害剤治療のヨーロッパ市場予測（2019年-2025年）
・血漿プロテアーゼC1阻害剤治療の中国市場予測（2019年-2025年）
・血漿プロテアーゼC1阻害剤治療の日本市場予測（2019年-2025年）
・血漿プロテアーゼC1阻害剤治療の東南アジア市場予測（2019年-2025年）
・血漿プロテアーゼC1阻害剤治療のインド市場予測（2019年-2025年）
...

The global Plasma Protease C1-inhibitor Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report studies the global Plasma Protease C1-inhibitor Treatment market status and forecast, categorizes the global Plasma Protease C1-inhibitor Treatment market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Major manufacturers covered in this report
Shire plc
CSL Limited
Sanquin
Pharming Group N.V.
…

In view of regional level, this report covers
United States
Europe
China
Japan
Southeast Asia
India

Segment by Type
by Drug Class
C1-inhibitors
Kallikrein Inhibitor (Kalbitor)
Selective Bradykinin B2 Receptor Antagonist (Firazyr)
by Dosage Type
Liquid/Injectable
Lyophilized

Segment by Application
Hospital Pharmacies
Independent Pharmacies and Outlets

レポート目次

Table of Contents

Global Plasma Protease C1-inhibitor Treatment Sales Market Report 2019
1 Plasma Protease C1-inhibitor Treatment Market Overview
1.1 Plasma Protease C1-inhibitor TreatmentProduct Overview
1.2 Plasma Protease C1-inhibitor Treatment Segment by Type
1.2.1 Global Plasma Protease C1-inhibitor Treatment Sales Comparison by Types (2014-2025)
1.2.2 C1-inhibitors
1.2.3 Kallikrein Inhibitor (Kalbitor)
1.2.4 Selective Bradykinin B2 Receptor Antagonist (Firazyr)
1.3 Plasma Protease C1-inhibitor Treatment Segment by Application
1.3.1 Global Plasma Protease C1-inhibitor Treatment Sales Comparison by Application (2014-2025)
1.3.1 Hospital Pharmacies
1.3.2 Independent Pharmacies and Outlets
1.4 Plasma Protease C1-inhibitor Treatment Market by Region
1.4.1 Global Plasma Protease C1-inhibitor Treatment Revenue Comparison by Region (2014-2025)
1.4.2 United States Plasma Protease C1-inhibitor Treatment Status and Prospect (2014-2025)
1.4.3 Europe Plasma Protease C1-inhibitor Treatment Status and Prospect (2014-2025)
1.4.4 China Plasma Protease C1-inhibitor Treatment Status and Prospect (2014-2025)
1.4.5 Japan Plasma Protease C1-inhibitor Treatment Status and Prospect (2014-2025)
1.4.6 Southeast Asia Plasma Protease C1-inhibitor Treatment Status and Prospect (2014-2025)
1.4.7 India Plasma Protease C1-inhibitor Treatment Status and Prospect (2014-2025)
1.5 Global Plasma Protease C1-inhibitor Treatment Sales and Revenue (2014-2025)
1.5.1 Global Plasma Protease C1-inhibitor Treatment Sales and Growth Rate (2014-2025)
1.5.2 Global Plasma Protease C1-inhibitor Treatment Revenue and Growth Rate (2014-2025)

2 Plasma Protease C1-inhibitor Treatment by Company, Region, Type and Application
2.1 Global Plasma Protease C1-inhibitor Treatment Market Competition by Companies
2.1.1 Global Plasma Protease C1-inhibitor Treatment Sales Market Share of Key Companies (2014-2019)
2.1.2 Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Company (2014-2019)
2.2 Global Plasma Protease C1-inhibitor Treatment Sales and Revenue by Region
2.2.1 Global Plasma Protease C1-inhibitor Treatment Sales Market Share by Region (2014-2019)
2.2.2 Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Region (2014-2019)
2.3 Global Plasma Protease C1-inhibitor Treatment Sales and Revenue by Type
2.3.1 Global Plasma Protease C1-inhibitor Treatment Sales Market Share by Type (2014-2019)
2.3.2 Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Type (2014-2019)
2.4 Global Plasma Protease C1-inhibitor Treatment Sales by Application

3 United States Plasma Protease C1-inhibitor Treatment Sales, Revenue and Price
3.1 United States Plasma Protease C1-inhibitor Treatment Sales and Revenue (2014-2019)
3.1.1 United States Plasma Protease C1-inhibitor Treatment Sales Growth Rate (2014-2019)
3.1.2 United States Plasma Protease C1-inhibitor Treatment Revenue Growth Rate (2014-2019)
3.1.3 United States Plasma Protease C1-inhibitor Treatment Price Trend (2014-2019)
3.2 United States Plasma Protease C1-inhibitor Treatment Sales Market Share by Company
3.3 United States Plasma Protease C1-inhibitor Treatment Sales Market Share by Type
3.4 United States Plasma Protease C1-inhibitor Treatment Sales Market Share by Application

4 Europe Plasma Protease C1-inhibitor Treatment Sales, Revenue and Price
4.1 Europe Plasma Protease C1-inhibitor Treatment Sales and Value (2014-2019)
4.1.1 Europe Plasma Protease C1-inhibitor Treatment Sales Growth Rate (2014-2019)
4.1.2 Europe Plasma Protease C1-inhibitor Treatment Revenue Growth Rate (2014-2019)
4.1.3 Europe Plasma Protease C1-inhibitor Treatment Price Trend (2014-2019)
4.2 Europe Plasma Protease C1-inhibitor Treatment Sales Market Share by Company
4.3 Europe Plasma Protease C1-inhibitor Treatment Sales Market Share by Type
4.4 Europe Plasma Protease C1-inhibitor Treatment Sales Market Share by Application

5 China Plasma Protease C1-inhibitor Treatment Sales, Revenue and Price
5.1 China Plasma Protease C1-inhibitor Treatment Sales and Revenue (2014-2019)
5.1.1 China Plasma Protease C1-inhibitor Treatment Sales Growth Rate (2014-2019)
5.1.2 China Plasma Protease C1-inhibitor Treatment Revenue Growth Rate (2014-2019)
5.1.3 China Plasma Protease C1-inhibitor Treatment Price Trend (2014-2019)
5.2 China Plasma Protease C1-inhibitor Treatment Sales Market Share by Company
5.3 China Plasma Protease C1-inhibitor Treatment Sales Market Share by Type
5.4 China Plasma Protease C1-inhibitor Treatment Sales Market Share by Application

6 Japan Plasma Protease C1-inhibitor Treatment Sales, Revenue and Price
6.1 Japan Plasma Protease C1-inhibitor Treatment Sales and Value (2014-2019)
6.1.1 Japan Plasma Protease C1-inhibitor Treatment Sales Growth Rate (2014-2019)
6.1.2 Japan Plasma Protease C1-inhibitor Treatment Revenue Growth Rate (2014-2019)
6.1.3 Japan Plasma Protease C1-inhibitor Treatment Price Trend (2014-2019)
6.2 Japan Plasma Protease C1-inhibitor Treatment Sales Market Share by Company
6.3 Japan Plasma Protease C1-inhibitor Treatment Sales Market Share by Type
6.4 Japan Plasma Protease C1-inhibitor Treatment Sales Market Share by Application

7 Southeast Asia Plasma Protease C1-inhibitor Treatment Sales, Revenue and Price
7.1 Southeast Asia Plasma Protease C1-inhibitor Treatment Sales and Value (2014-2019)
7.1.1 Southeast Asia Plasma Protease C1-inhibitor Treatment Sales Growth Rate (2014-2019)
7.1.2 Southeast Asia Plasma Protease C1-inhibitor Treatment Revenue Growth Rate (2014-2019)
7.1.3 Southeast Asia Plasma Protease C1-inhibitor Treatment Price Trend (2014-2019)
7.2 Southeast Asia Plasma Protease C1-inhibitor Treatment Sales Market Share by Company
7.3 Southeast Asia Plasma Protease C1-inhibitor Treatment Sales Market Share by Type
7.4 Southeast Asia Plasma Protease C1-inhibitor Treatment Sales Market Share by Application

8 India Plasma Protease C1-inhibitor Treatment Sales, Revenue and Price
8.1 India Plasma Protease C1-inhibitor Treatment Sales and Value (2014-2019)
8.1.1 India Plasma Protease C1-inhibitor Treatment Sales Growth Rate (2014-2019)
8.1.2 India Plasma Protease C1-inhibitor Treatment Revenue Growth Rate (2014-2019)
8.1.3 India Plasma Protease C1-inhibitor Treatment Price Trend (2014-2019)
8.2 India Plasma Protease C1-inhibitor Treatment Sales Market Share by Company
8.3 India Plasma Protease C1-inhibitor Treatment Sales Market Share by Type
8.4 India Plasma Protease C1-inhibitor Treatment Sales Market Share by Application

9 Company Profiles and Key Figures in Plasma Protease C1-inhibitor Treatment Business
9.1 Shire plc
9.1.1 Shire plc Plasma Protease C1-inhibitor Treatment Production Sites and Area Served
9.1.2 Plasma Protease C1-inhibitor Treatment Specification and Application
9.1.3 Shire plc Plasma Protease C1-inhibitor Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.1.4 Main Business and Markets Served
9.2 CSL Limited
9.2.1 CSL Limited Plasma Protease C1-inhibitor Treatment Production Sites and Area Served
9.2.2 Plasma Protease C1-inhibitor Treatment Specification and Application
9.2.3 CSL Limited Plasma Protease C1-inhibitor Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.2.4 Main Business and Markets Served
9.3 Sanquin
9.3.1 Sanquin Plasma Protease C1-inhibitor Treatment Production Sites and Area Served
9.3.2 Plasma Protease C1-inhibitor Treatment Specification and Application
9.3.3 Sanquin Plasma Protease C1-inhibitor Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.3.4 Main Business and Markets Served
9.4 Pharming Group N.V.
9.4.1 Pharming Group N.V. Plasma Protease C1-inhibitor Treatment Production Sites and Area Served
9.4.2 Plasma Protease C1-inhibitor Treatment Specification and Application
9.4.3 Pharming Group N.V. Plasma Protease C1-inhibitor Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.4.4 Main Business and Markets Served
…

10 Plasma Protease C1-inhibitor Treatment Maufacturing Cost Analysis
10.1 Plasma Protease C1-inhibitor Treatment Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Key Raw Materials Price Trend
10.1.3 Key Suppliers of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.3 Manufacturing Process Analysis of Plasma Protease C1-inhibitor Treatment
10.4 Plasma Protease C1-inhibitor Treatment Industrial Chain Analysis

11 Marketing Channel, Distributors and Customers
11.1 Marketing Channel
11.1.1 Direct Marketing
11.1.2 Indirect Marketing
11.2 Plasma Protease C1-inhibitor Treatment Distributors List
11.3 Plasma Protease C1-inhibitor Treatment Customers

12 Market Dynamics
12.1 Market Trends
12.2 Opportunities
12.3 Market Drivers
12.4 Challenges
12.5 Influence Factors

13 Plasma Protease C1-inhibitor Treatment Market Forecast
13.1 Global Plasma Protease C1-inhibitor Treatment Sales, Revenue and Price Forecast
13.1.1 Global Plasma Protease C1-inhibitor Treatment Sales Growth Forecast (2019-2025)
13.1.2 Global Plasma Protease C1-inhibitor Treatment Revenue Growth Forecast (2019-2025)
13.1.3 Global Plasma Protease C1-inhibitor Treatment Price Trend Forecast (2019-2025)
13.2 Global Plasma Protease C1-inhibitor Treatment Forecast by Region
13.2.1 Global Plasma Protease C1-inhibitor Treatment Sales Growth Forecast by Region (2019-2025)
13.2.2 Global Plasma Protease C1-inhibitor Treatment Revenue Growth Forecast by Region (2019-2025)
13.2.3 United States Plasma Protease C1-inhibitor Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.4 Europe Plasma Protease C1-inhibitor Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.5 China Plasma Protease C1-inhibitor Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.6 Japan Plasma Protease C1-inhibitor Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.7 Southeast Asia Plasma Protease C1-inhibitor Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.8 India Plasma Protease C1-inhibitor Treatment Sales, Revenue Growth Forecast (2019-2025)
13.3 Global Plasma Protease C1-inhibitor Treatment Forecast by Type
13.3.1 Global Plasma Protease C1-inhibitor Treatment Sales Forecast by Type (2019-2025)
13.3.2 Global Plasma Protease C1-inhibitor Treatment Revenue Forecast by Type (2019-2025)
13.3.3 Global Plasma Protease C1-inhibitor Treatment Price Forecast by Type (2019-2025)
13.4 Global Plasma Protease C1-inhibitor Treatment Forecast by Application

14 Research Findings and Conclusion

15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer

List of Tables and Figures

Market Breakdown by Region: Plasma Protease C1-inhibitor Treatment Sales (K Units) and Value (Revenue: Million US$)
Market Breakdown by Type: Plasma Protease C1-inhibitor Treatment Sales (K Units) and Revenue (Million US$)
Market Breakdown by Application: Plasma Protease C1-inhibitor Treatment Sales (Jan)
Figure Plasma Protease C1-inhibitor Treatment Product Picture
Table Global Plasma Protease C1-inhibitor Treatment Sales (K Units) Growth Rate by Types (2014-2025)
Figure Global Plasma Protease C1-inhibitor Treatment Sales Market Share by Types in 2018
Figure C1-inhibitors Product Picture
Figure Kallikrein Inhibitor (Kalbitor) Product Picture
Figure Selective Bradykinin B2 Receptor Antagonist (Firazyr) Product Picture
Table Global Plasma Protease C1-inhibitor Treatment Sales (K Units) Comparison by Application (2014-2025)
Figure Global Sales Market Share of Plasma Protease C1-inhibitor Treatment by Application in 2018
Figure Hospital Pharmacies Examples
Figure Independent Pharmacies and Outlets Examples
Table Global Market Plasma Protease C1-inhibitor Treatment Revenue (Million USD) Comparison by Region 2014-2025
Figure United States Plasma Protease C1-inhibitor Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure Europe Plasma Protease C1-inhibitor Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Plasma Protease C1-inhibitor Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Plasma Protease C1-inhibitor Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure Southeast Asia Plasma Protease C1-inhibitor Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure India Plasma Protease C1-inhibitor Treatment Revenue (Million USD) and Growth Rate (2014-2025)
Figure Global Plasma Protease C1-inhibitor Treatment Sales (K Units) Growth Rate (2014-2025)
Figure Global Plasma Protease C1-inhibitor Treatment Revenue (Million USD) Growth Rate (2014-2025)
Table Global Plasma Protease C1-inhibitor Treatment Sales (K Units) of Key Companies (2014-2019)
Figure Global Plasma Protease C1-inhibitor Treatment Sales by Company in 2018
Table Global Plasma Protease C1-inhibitor Treatment Sales Share by Company (2014-2019)
Figure Global Plasma Protease C1-inhibitor Treatment Sales Share by Company in 2018
Table Global Plasma Protease C1-inhibitor Treatment Revenue (Million USD) by Company (2014-2019)
Figure Global Plasma Protease C1-inhibitor Treatment Revenue (Million USD) by Company in 2018
Table Global Plasma Protease C1-inhibitor Treatment Revenue Share by Company (2014-2019)
Figure Global Plasma Protease C1-inhibitor Treatment Revenue Share by Company in 2018
Table Global Plasma Protease C1-inhibitor Treatment Sales (K Units) Market Share by Region (2014-2019)
Table Global Plasma Protease C1-inhibitor Treatment Sales Share by Region (2014-2019)
Figure Global Plasma Protease C1-inhibitor Treatment Sales Share by Region in 2018
Table Global Plasma Protease C1-inhibitor Treatment Revenue (Million USD) Market Share by Region (2014-2019)
Table Global Plasma Protease C1-inhibitor Treatment Revenue Share by Region (2014-2019)
Figure Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Region In 2018
Table Global Plasma Protease C1-inhibitor Treatment Sales (K Units) by Type (2014-2019)
Table Global Plasma Protease C1-inhibitor Treatment Sales Share by Type (2014-2019)
Figure Global Plasma Protease C1-inhibitor Treatment Sales Growth Rate by Type in 2018
Table Global Plasma Protease C1-inhibitor Treatment Revenue (Million USD) Market Share by Type (2014-2019)
Table Global Plasma Protease C1-inhibitor Treatment Revenue Share by Type (2014-2019)
Figure Global Plasma Protease C1-inhibitor Treatment Revenue Growth Rate by Type in 2018
Table Global Plasma Protease C1-inhibitor Treatment Sales Market Share by Application (2014-2019)
Table Global Plasma Protease C1-inhibitor Treatment Sales Share by Application (2014-2019)
Figure Global Plasma Protease C1-inhibitor Treatment Sales Market Share by Application in 2018
Figure United States Plasma Protease C1-inhibitor Treatment Sales (K Units) and Growth Rate (2014-2019)
Figure United States Plasma Protease C1-inhibitor Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure United States Plasma Protease C1-inhibitor Treatment Price (USD/Unit) Trend (2014-2019)
Table United States Plasma Protease C1-inhibitor Treatment Sales (K Units) by Company (2014-2019)
Table United States Plasma Protease C1-inhibitor Treatment Sales Market Share by Company (2014-2019)
Figure United States Plasma Protease C1-inhibitor Treatment Sales Market Share by Company in 2018
Table United States Plasma Protease C1-inhibitor Treatment Sales (K Units) by Type (2014-2019)
Table United States Plasma Protease C1-inhibitor Treatment Sales Market Share by Type (2014-2019)
Figure United States Plasma Protease C1-inhibitor Treatment Sales Market Share by Type in 2018
Table United States Plasma Protease C1-inhibitor Treatment Sales (K Units) by Application (2014-2019)
Table United States Plasma Protease C1-inhibitor Treatment Sales Market Share by Application (2014-2019)
Figure United States Plasma Protease C1-inhibitor Treatment Sales Market Share by Application in 2018
Figure Europe Plasma Protease C1-inhibitor Treatment Sales (K Units) and Growth Rate (2014-2019)
Figure Europe Plasma Protease C1-inhibitor Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure Europe Plasma Protease C1-inhibitor Treatment Price (USD/Unit) Trend (2014-2019)
Table Europe Plasma Protease C1-inhibitor Treatment Sales (K Units) by Company (2014-2019)
Table Europe Plasma Protease C1-inhibitor Treatment Sales Market Share by Company (2014-2019)
Figure Europe Plasma Protease C1-inhibitor Treatment Sales Market Share by Company in 2018
Table Europe Plasma Protease C1-inhibitor Treatment Sales (K Units) by Type (2014-2019)
Table Europe Plasma Protease C1-inhibitor Treatment Sales Market Share by Type (2014-2019)
Figure Europe Plasma Protease C1-inhibitor Treatment Sales Market Share by Type in 2018
Table Europe Plasma Protease C1-inhibitor Treatment Sales (K Units) by Application (2014-2019)
Table Europe Plasma Protease C1-inhibitor Treatment Sales Market Share by Application (2014-2019)
Figure Europe Plasma Protease C1-inhibitor Treatment Sales Market Share by Application in 2018
Figure China Plasma Protease C1-inhibitor Treatment Sales (K Units) and Growth Rate (2014-2019)
Figure China Plasma Protease C1-inhibitor Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure China Plasma Protease C1-inhibitor Treatment Price (USD/Unit) Trend (2014-2019)
Table China Plasma Protease C1-inhibitor Treatment Sales (K Units) by Company (2014-2019)
Table China Plasma Protease C1-inhibitor Treatment Sales Market Share by Company (2014-2019)
Figure China Plasma Protease C1-inhibitor Treatment Sales Market Share by Company in 2018
Table China Plasma Protease C1-inhibitor Treatment Sales (K Units) by Type (2014-2019)
Table China Plasma Protease C1-inhibitor Treatment Sales Market Share by Type (2014-2019)
Figure China Plasma Protease C1-inhibitor Treatment Sales Market Share by Type in 2018
Table China Plasma Protease C1-inhibitor Treatment Sales (K Units) by Application (2014-2019)
Table China Plasma Protease C1-inhibitor Treatment Sales Market Share by Application (2014-2019)
Figure China Plasma Protease C1-inhibitor Treatment Sales Market Share by Application in 2018
Figure Japan Plasma Protease C1-inhibitor Treatment Sales (K Units) and Growth Rate (2014-2019)
Figure Japan Plasma Protease C1-inhibitor Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure Japan Plasma Protease C1-inhibitor Treatment Price (USD/Unit) Trend (2014-2019)
Table Japan Plasma Protease C1-inhibitor Treatment Sales (K Units) by Company (2014-2019)
Table Japan Plasma Protease C1-inhibitor Treatment Sales Market Share by Company (2014-2019)
Figure Japan Plasma Protease C1-inhibitor Treatment Sales Market Share by Company in 2018
Table Japan Plasma Protease C1-inhibitor Treatment Sales (K Units) by Type (2014-2019)
Table Japan Plasma Protease C1-inhibitor Treatment Sales Market Share by Type (2014-2019)
Figure Japan Plasma Protease C1-inhibitor Treatment Sales Market Share by Type in 2018
Table Japan Plasma Protease C1-inhibitor Treatment Sales (K Units) by Application (2014-2019)
Table Japan Plasma Protease C1-inhibitor Treatment Sales Market Share by Application (2014-2019)
Figure Japan Plasma Protease C1-inhibitor Treatment Sales Market Share by Application in 2018
Figure Southeast Asia Plasma Protease C1-inhibitor Treatment Sales (K Units) and Growth Rate (2014-2019)
Figure Southeast Asia Plasma Protease C1-inhibitor Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure Southeast Asia Plasma Protease C1-inhibitor Treatment Price (USD/Unit) Trend (2014-2019)
Table Southeast Asia Plasma Protease C1-inhibitor Treatment Sales (K Units) by Company (2014-2019)
Table Southeast Asia Plasma Protease C1-inhibitor Treatment Sales Market Share by Company (2014-2019)
Figure Southeast Asia Plasma Protease C1-inhibitor Treatment Sales Market Share by Company in 2018
Table Southeast Asia Plasma Protease C1-inhibitor Treatment Sales (K Units) by Type (2014-2019)
Table Southeast Asia Plasma Protease C1-inhibitor Treatment Sales Market Share by Type (2014-2019)
Figure Southeast Asia Plasma Protease C1-inhibitor Treatment Sales Market Share by Type in 2018
Table Southeast Asia Plasma Protease C1-inhibitor Treatment Sales (K Units) by Application (2014-2019)
Table Southeast Asia Plasma Protease C1-inhibitor Treatment Sales Market Share by Application (2014-2019)
Figure Southeast Asia Plasma Protease C1-inhibitor Treatment Sales Market Share by Application in 2018
Figure India Plasma Protease C1-inhibitor Treatment Sales (K Units) and Growth Rate (2014-2019)
Figure India Plasma Protease C1-inhibitor Treatment Revenue (Million USD) and Growth Rate (2014-2019)
Figure India Plasma Protease C1-inhibitor Treatment Price (USD/Unit) Trend (2014-2019)
Table India Plasma Protease C1-inhibitor Treatment Sales (K Units) by Company (2014-2019)
Table India Plasma Protease C1-inhibitor Treatment Sales Market Share by Company (2014-2019)
Figure India Plasma Protease C1-inhibitor Treatment Sales Market Share by Company in 2018
Table India Plasma Protease C1-inhibitor Treatment Sales (K Units) by Type (2014-2019)
Table India Plasma Protease C1-inhibitor Treatment Sales Market Share by Type (2014-2019)
Figure India Plasma Protease C1-inhibitor Treatment Sales Market Share by Type in 2018
Table India Plasma Protease C1-inhibitor Treatment Sales (K Units) by Application (2014-2019)
Table India Plasma Protease C1-inhibitor Treatment Sales Market Share by Application (2014-2019)
Figure India Plasma Protease C1-inhibitor Treatment Sales Market Share by Application in 2018
Table Shire plc Plasma Protease C1-inhibitor Treatment Production Sites and Area Served
Table Shire plc Plasma Protease C1-inhibitor Treatment Specification and Application
Table Shire plc Plasma Protease C1-inhibitor Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Shire plc Plasma Protease C1-inhibitor Treatment Sales Growth Rate (2014-2019)
Figure Shire plc Plasma Protease C1-inhibitor Treatment Revenue Share in International Market (2014-2019)
Figure Shire plc Plasma Protease C1-inhibitor Treatment Main Business and Markets Served
Table CSL Limited Plasma Protease C1-inhibitor Treatment Production Sites and Area Served
Table CSL Limited Plasma Protease C1-inhibitor Treatment Specification and Application
Table CSL Limited Plasma Protease C1-inhibitor Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure CSL Limited Plasma Protease C1-inhibitor Treatment Sales Growth Rate (2014-2019)
Figure CSL Limited Plasma Protease C1-inhibitor Treatment Revenue Share in International Market (2014-2019)
Figure CSL Limited Plasma Protease C1-inhibitor Treatment Main Business and Markets Served
Table Sanquin Plasma Protease C1-inhibitor Treatment Production Sites and Area Served
Table Sanquin Plasma Protease C1-inhibitor Treatment Specification and Application
Table Sanquin Plasma Protease C1-inhibitor Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Sanquin Plasma Protease C1-inhibitor Treatment Sales Growth Rate (2014-2019)
Figure Sanquin Plasma Protease C1-inhibitor Treatment Revenue Share in International Market (2014-2019)
Figure Sanquin Plasma Protease C1-inhibitor Treatment Main Business and Markets Served
Table Pharming Group N.V. Plasma Protease C1-inhibitor Treatment Production Sites and Area Served
Table Pharming Group N.V. Plasma Protease C1-inhibitor Treatment Specification and Application
Table Pharming Group N.V. Plasma Protease C1-inhibitor Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Pharming Group N.V. Plasma Protease C1-inhibitor Treatment Sales Growth Rate (2014-2019)
Figure Pharming Group N.V. Plasma Protease C1-inhibitor Treatment Revenue Share in International Market (2014-2019)
Figure Pharming Group N.V. Plasma Protease C1-inhibitor Treatment Main Business and Markets Served
Table Production Base and Market Concentration Rate of Raw Material
Figure Key Raw Materials Price Trend
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Plasma Protease C1-inhibitor Treatment
Figure Manufacturing Process Analysis of Plasma Protease C1-inhibitor Treatment
Figure Plasma Protease C1-inhibitor Treatment Industrial Chain Analysis
Table Plasma Protease C1-inhibitor Treatment Distributors List
Table Plasma Protease C1-inhibitor Treatment Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Figure Global Plasma Protease C1-inhibitor Treatment Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Global Plasma Protease C1-inhibitor Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Global Plasma Protease C1-inhibitor Treatment Price (USD/Unit) and Trend Forecast (2019-2025)
Table Global Plasma Protease C1-inhibitor Treatment Sales (K Units) Forecast by Regions (2019-2025)
Figure Global Plasma Protease C1-inhibitor Treatment Sales Market Share Forecast by Regions (2019-2025)
Figure Global Plasma Protease C1-inhibitor Treatment Sales Market Share Forecast by Regions in 2025
Table Global Plasma Protease C1-inhibitor Treatment Revenue (Million USD) Forecast by Regions (2019-2025)
Figure Global Plasma Protease C1-inhibitor Treatment Revenue Market Share Forecast by Regions (2019-2025)
Figure Global Plasma Protease C1-inhibitor Treatment Revenue Market Share Forecast by Regions in 2025
Figure United States Plasma Protease C1-inhibitor Treatment Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure United States Plasma Protease C1-inhibitor Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Europe Plasma Protease C1-inhibitor Treatment Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Europe Plasma Protease C1-inhibitor Treatment Revenue and Growth Rate Forecast (2019-2025)
Figure China Plasma Protease C1-inhibitor Treatment Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure China Plasma Protease C1-inhibitor Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Japan Plasma Protease C1-inhibitor Treatment Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Japan Plasma Protease C1-inhibitor Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Southeast Asia Plasma Protease C1-inhibitor Treatment Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Southeast Asia Plasma Protease C1-inhibitor Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure India Plasma Protease C1-inhibitor Treatment Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure India Plasma Protease C1-inhibitor Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Table Global Plasma Protease C1-inhibitor Treatment Sales (K Units) Forecast by Type (2019-2025)
Figure Global Plasma Protease C1-inhibitor Treatment Sales Market Share Forecast by Type (2019-2025)
Table Global Plasma Protease C1-inhibitor Treatment Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Plasma Protease C1-inhibitor Treatment Revenue Market Share Forecast by Type (2019-2025)
Table Global Plasma Protease C1-inhibitor Treatment Price (USD/Unit) Forecast by Type (2019-2025)
Table Global Plasma Protease C1-inhibitor Treatment Sales (K Units) Forecast by Application (2019-2025)
Figure Global Plasma Protease C1-inhibitor Treatment Sales Market Share Forecast by Application (2019-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

世界のプラズマ画分市場：市場規模・現状・予測

Global Plasma Fraction Market Size, Status and Forecast 2019-2025
QYR9N7833 2019年6月14日 97Pages
当資料は、プラズマ画分のグローバル市場について調査・分析したレポートで、種類別（プロテアーゼ阻害剤、プロテアーゼ、線維素溶解タンパク質、凝固因子、抗凝固タンパク質）、用途別（病院、診療所、外来手術センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予...

世界のプラスミノーゲンアクチベーター阻害剤1市場2019

Global Plasminogen Activator Inhibitor 1 Sales Market Report 2019
QYR9N3461 2019年6月13日 105Pages
本調査レポートでは、プラスミノーゲンアクチベーター阻害剤1の世界市場について調査・分析し、プラスミノーゲンアクチベーター阻害剤1のメーカー別販売量、市場シェア分析、種類別販売分析（SK-216、THR-18、デフィブロチドナトリウム、CT-140、その他）、用途別販売分析（血栓症、急性虚血性脳卒中、...

世界の反すう動物飼料プロテアーゼ市場2019

Global Ruminant Feed Protease Sales Market Report 2019
QYR9N4139 2019年6月13日 109Pages
本調査レポートでは、反すう動物飼料プロテアーゼの世界市場について調査・分析し、反すう動物飼料プロテアーゼのメーカー別販売量、市場シェア分析、種類別販売分析（天然、合成）、用途別販売分析（牛、羊、その他）、地域別販売分析（米国、ヨーロッパ、中国、日本、東南アジア、インド）、価格動向、企業動向、市場規模...

世界の家禽飼料プロテアーゼ市場2019

Global Poultry Feed Protease Sales Market Report 2019
QYR9N3674 2019年6月13日 103Pages
本調査レポートでは、家禽飼料プロテアーゼの世界市場について調査・分析し、家禽飼料プロテアーゼのメーカー別販売量、市場シェア分析、種類別販売分析（天然、合成）、用途別販売分析（チキン、アヒル、ガチョウ、その他）、地域別販売分析（米国、ヨーロッパ、中国、日本、東南アジア、インド）、価格動向、企業動向、市...

世界の核因子κBキナーゼサブユニットベータの阻害剤市場2019

Global Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta Sales Market Report 2019
QYR9N1955 2019年6月10日 102Pages
本調査レポートでは、核因子κBキナーゼサブユニットベータの阻害剤の世界市場について調査・分析し、核因子κBキナーゼサブユニットベータの阻害剤のメーカー別販売量、市場シェア分析、種類別販売分析（TLX-1423、IMD-0560、EC-70124、その他）、用途別販売分析（大腸がん、乳がん、膵がん、前...

世界のセリンプロテアーゼ市場2019

Global Serine Protease Sales Market Report 2019
QYR9N4287 2019年6月13日 104Pages
本調査レポートでは、セリンプロテアーゼの世界市場について調査・分析し、セリンプロテアーゼのメーカー別販売量、市場シェア分析、種類別販売分析（C1r
、C1s
、C3a
、C3b
）、用途別販売分析（消化器系、血液凝固システム、補完システム、その他）、地...

世界の油田腐食とスケール防止剤市場2019

Global Oilfield Corrosion and Scale Inhibitor Sales Market Report 2019
QYR9N3029 2019年6月13日 101Pages
本調査レポートでは、油田腐食とスケール防止剤の世界市場について調査・分析し、油田腐食とスケール防止剤のメーカー別販売量、市場シェア分析、種類別販売分析（無機リン酸塩、有機リン化合物、ポリマースケール防止剤、その他）、用途別販売分析（水処理、石油ガス、その他）、地域別販売分析（米国、ヨーロッパ、中国、...

世界のプラズマセパレータ市場2019

Global Plasma Separators Sales Market Report 2019
QYR9N3460 2019年6月13日 108Pages
本調査レポートでは、プラズマセパレータの世界市場について調査・分析し、プラズマセパレータのメーカー別販売量、市場シェア分析、種類別販売分析（少量サンプル用、大量サンプル用）、用途別販売分析（病院、診療所、研究所、その他）、地域別販売分析（米国、ヨーロッパ、中国、日本、東南アジア、インド）、価格動向、...

世界のプラズマ炉市場2019

Global Plasma Furnace Sales Market Report 2019
QYR9N3458 2019年6月13日 106Pages
本調査レポートでは、プラズマ炉の世界市場について調査・分析し、プラズマ炉のメーカー別販売量、市場シェア分析、種類別販売分析（セラミックるつぼプラズマ炉、晶析装置プラズマ炉、スカルプラズマ炉）、用途別販売分析（冶金、廃棄物処理、その他）、地域別販売分析（米国、ヨーロッパ、中国、日本、東南アジア、インド...

世界のPARP（ポリADPリボースポリメラーゼ）阻害剤市場：市場規模・現状・予測

Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size, Status and Forecast 2019-2025
QYR9N7768 2019年6月14日 93Pages
当資料は、PARP（ポリADPリボースポリメラーゼ）阻害剤のグローバル市場について調査・分析したレポートで、種類別（開始フェーズI、開始フェーズII、開始フェーズIII）、用途別（病院、ドラッグストア、オンライン）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模...

世界のプラズマ画分市場：市場規模・現状・予測 Blood plasma fractionation refers to the general processes of separating the various components of blood plasma, which in turn is a component of blood obtained through blood fractionation.Increasing awareness about the disease and increasing disposable income are expected to boost the growth of the …
世界の家禽飼料プロテアーゼ市場2019 Exogenous proteases in feed can be an option to reduce dietary protein levels maintaining high performance. Enzymatic hydrolysis of proteins is the method of choice in processing animal by-products or plant-source feedstuffs The global Poultry Feed Protease market was valued at xx million US$ in 201…
世界の反すう動物飼料プロテアーゼ市場2019 Exogenous proteases in feed can be an option to reduce dietary protein levels maintaining high performance. Enzymatic hydrolysis of proteins is the method of choice in processing animal by-products or plant-source feedstuffs The global Ruminant Feed Protease market was valued at xx million US$ in 20…
世界のセリンプロテアーゼ市場2019 Serine proteases is a family of proteases that break peptide bonds in macromolecular proteins into smaller proteins The global Serine Protease market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report studies …
世界のプラスミノーゲンアクチベーター阻害剤1市場2019 The global Plasminogen Activator Inhibitor 1 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Plasminogen Activator Inhibitor 1 market status and forecast, categorizes the global Plasminogen …